Registration Dossier

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vivo

Description of key information
No genetic toxicity found in the different tests for the analogues.
Link to relevant study records
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
weight of evidence
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: OECD-Study with insufficient discussions
according to guideline
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
Type of assay:
micronucleus assay
Details on test animals or test system and environmental conditions:
- Source: F. Winkelmann, Borchen
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 28 - 42 g
- Assigned to test groups randomly: yes, using a randomisation plan produced by teh Institute of Biometrics, BAYER AG, Wuppertal
- Fasting period before study: no
- Housing: Makrolon cages type I and II, bedding of soft wood granules
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week

- Temperature (°C): 22 to 24 °C
- Humidity (%): 50 %
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12
Route of administration:
other: oral stomach tube
polyethylene glycol 400
Details on exposure:
a pilot study indicated 800 mg / kg bw as concentration for the test.
800 mg /kg bw were dissolved in polyethylene glycol 400.
Via stomach tube 5 ml / kg bw were administered.
Frequency of treatment:
Post exposure period:
24 to 72 hours
Doses / Concentrations:
800 mg / kgbw
other: nominal in vehicle
No. of animals per sex per dose:
10 animals, 5 male, 5 female
Control animals:
Positive control(s):
- Justification for choice of positive control(s): cyclophosphamide is a known clastogen
- Route of administration: oral via stomach tube
- Doses / concentrations: 20 mg / kg bw, dissolved in demineralised water, 10 ml / kg were administered
Tissues and cell types examined:
bone marrow
Details of tissue and slide preparation:

1. At least one intact femur was prepared from each
sacrificed animal (not pretreated with a spindIe
inhibitor). A suitable instrument was used to
sever the pelvic bones and calf area.
2. The femur was separated from muscular tissue.
3. The lowerleg stump with knee and all attached
soft parts in the distal epiphyseal cartilage
were remtoved by a gentIe pull at the distal end.
4. The proximal end of the femur was opened at its
extreme end with a suitable instrument, e.g.
fine scissors, so that a small opening of the
bone marrow channel became visible.
5. A suitable tube was filled with sufficient fetal
calf serum.
6. Some serum was drawn from the tube into a suitable
syringe, with thin cannula.
7. The cannula was pushed into the open end of the
marrow cavity.
8. The femur was then completely immersed in the calf
serum and pressed against the wall of the tube,
so that it could not slip off.
9. The contents were then flushed several times, and
the bone marrow passed into the serum as a fine
10. FinaIly, the flushing could be repeated from the
other end after it was opened.
11. The tube containing the serum and bone marrow
was centrifuged in a suitable centrifuge at
approximately 1000 rpm for five minutes.
12. The supernatant was removed with a suitable
pipette (e.g. Pasteur pipette) except for a
small residue.
13. The sediment was mixed until the suspension
was homogeneous.
14. one drop of the viscous suspension was placed
on the thoroughly cleaned slide and spread
with a suitable object, e.g. a slide, so that
the smear could be properly evaluated.
15. The labelled slides were dried overnight.
If fresh smears are to be stained, they must
be dried for a short period with heat.

Staining of smears
The smears were stained automatically with an Ames Hema-Tek
Slide Stainer of Miles company. The slides were then
"destained" with methanol and rinsed with deionized water.
They were then left to dry.

the slides were analysed with a light microscope at a magnification of 1000
Evaluation criteria:
ratio of polychromatic to normochromatic erythrocytes
The Preventol CI8-100 group with the highest mean, if this
superceded the negative control mean, and the positive
control were checked by Wilcoxon's non-parametric rank sum
test in respect to the count of polychromatic erythrocytes
with micronuclei and the rate of normochromatic
erythrocytes. A variation is considered statistically
significant if its error probability is below 5% and the
treatment group figure is higher than the negative
control's .
The rate of normochromatic erythrocytes with micronuclei is
examined if the micronucleus rate for polychromatic
erythrocytes was already relevantly increased. In this case,
the group with the highest mean 1s compared with the
negative control using the one-sided chi 2-test. A variation
was considered statistically significant if the error
probability is below 5% and the treatment group figure is
higher than the negative control's.

In addition, standard deviations (1s ranges) were calculated
for all the means.
Vehicle controls validity:
not examined
Negative controls validity:
Positive controls validity:
Additional information on results:
- Dose range: 500/750/850/1000 mg/kg bw
- Clinical signs of toxicity in test animals: apathy, reduced motility, unkempt coat, lateral position, abdominal position, cramp, convulsion, rapid breathing

- Induction of micronuclei (for Micronucleus assay): No, 0.9 - 1.3 micronucleated cell per 1000 NCE/PCE
- Ratio of PCE/NCE (for Micronucleus assay): 1.028 - 1.084

Negative control
- Induction of micronuclei (for Micronucleus assay): No, 0.8 - 1.0 micronucleated cell per 1000 NCE/PCE
- Ratio of PCE/NCE (for Micronucleus assay): 0.867

Positive control
- Induction of micronuclei (for Micronucleus assay): No, 0.5 - 13.4 micronucleated cell per 1000 NCE/PCE
- Ratio of PCE/NCE (for Micronucleus assay): 1.133
Interpretation of results (migrated information): negative
There is no sign of genotoxicity arising from this study.
In comparison with the negative control, no alteration in the ratio of polychromatic to normochromatic erythocytes was observed.
Further, there is no variation in regard to incidence of micronucleated cells between the negative control and the test groups.
In the positive control group there is a significant change in the incidence of micronuclei compared to the negative control.
Executive summary:

For Benzotriazole (Herbold 1987) and Tolyltriazole (Lehn 1987) well-conducted in vivo studies are available showing no genetic toxicity for micronucleus formation in mice. This means that a similar result Sodium Benzotriazolate can be anticipated.


Sodium Benzotriazolate is not genotoxic with respect to micronucleus formation, based on a read across approach.


A DNEL for oral, dermal and/or inhalation route can be based on this information.

Classification and labelling are / are not needed for this endpoint.

A risk characterisation will be performed because the substance is classified for oral toxicity.


Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Additional information from genetic toxicity in vivo:

Justification for selection of genetic toxicity endpoint
in vivo and in vitro Studies from analogues (Benzotriazole and Tolyltriazole) are available and fulfill the
REACH repuirements of EC 1907/2006, Annex VII, 8.4.1 and Annex VIII, 8.4.2 and 8.4.3.
The in vivo micronucleus test for Benzotriazole is selected as it is the most sensitive endpoint tested and the
analogue is most similar to the substance.

Justification for classification or non-classification

The information on genetic toxicity are conclusive but not sufficient for a classification according Regulation (EC) No. 1272/2008.